LAVI — Lavipharm SA Cashflow Statement
0.000.00%
Last trade - 00:00- €136.47m
- €164.69m
- €52.95m
- 41
- 32
- 46
- 30
Annual cashflow statement for Lavipharm SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 3.38 | 2.75 | 2.14 | 3.13 | 3.6 |
| Depreciation | |||||
| Non-Cash Items | 3.54 | 4.17 | 4.8 | 1.68 | 5.04 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -5.63 | -4.74 | -5.3 | -8.87 | -8.58 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 2.85 | 3.82 | 3.35 | 0.284 | 4.64 |
| Capital Expenditures | -1.48 | -1.92 | -35.6 | -4.12 | -9.64 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.004 | 0.034 | 0.026 | 0.659 | 0.144 |
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.47 | -1.88 | -35.6 | -3.46 | -9.5 |
| Financing Cash Flow Items | — | — | — | -0.001 | -0.659 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1.18 | -2.23 | 48.8 | -6.63 | 2.16 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.2 | -0.294 | 16.6 | -9.81 | -2.7 |